S. 2560 (109th): Office of National Drug Control Policy Reauthorization Act of 2006

Introduced:
Apr 06, 2006 (109th Congress, 2005–2006)
Status:
Died (Reported by Committee)
See Instead:

H.R. 6344 (same title)
Signed by the President — Dec 29, 2006

Sponsor
Arlen Specter
Senator from Pennsylvania
Party
Democrat
Text
Read Text »
Last Updated
May 25, 2006
Length
170 pages
Related Bills
H.R. 6344 (Related)
Office of National Drug Control Policy Reauthorization Act of 2006

Signed by the President
Dec 29, 2006

H.R. 2829 (Related)
Office of National Drug Control Policy Reauthorization Act of 2005

Passed House
Last Action: Mar 09, 2006

 
Status

This bill was introduced on May 25, 2006, in a previous session of Congress, but was not enacted.

Progress
Introduced Apr 06, 2006
Referred to Committee Apr 06, 2006
Reported by Committee May 25, 2006
 
Full Title

A bill to reauthorize the Office of National Drug Control Policy.

Summary

No summaries available.

Cosponsors
5 cosponsors (3D, 2R) (show)
Committees

Senate Judiciary

The committee chair determines whether a bill will move past the committee stage.

 
Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Widget

Get a bill status widget for your website »

Citation

Click a format for a citation suggestion:

Notes

S. stands for Senate bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


5/25/2006--Reported to Senate amended.
Office of National Drug Control Policy Reauthorization Act of 2006 -
Title I - Organization of Office of National Drug Control Policy and Roles and Responsibilities
Section 101 -
Amends the Office of National Drug Control Policy Reauthorization Act of 1998 (ONDCPRA) to include in the definition of demand reduction activities international drug abuse education, prevention, treatment, research, rehabilitation activities, and interventions for drug abuse and dependence.
Includes within the National Drug Control Program activities involving supply reduction, demand reduction, or state and local affairs.
Redefines "state and local affairs" to include coordination and enhancement of federal, state, and local law enforcement intelligence gathering initiatives relating to drug control among domestic law enforcement agencies.
Expands the definition of "supply reduction" activities to include: (1) law enforcement outside the United States; (2) source country programs; (3) activities to control international trafficking in, and availability of, illegal drugs; (4) activities to conduct and promote international law enforcement programs and policies to reduce the supply of drugs; and (5) sharing of domestic and foreign intelligence information.
Section 102 -
Includes as a duty of the Office of National Drug Control Policy (Office) the development of specific goals and performance measurements for assessing the effectiveness of national drug control policy and programs. Revises the duties of the Deputy Directors of the Office.
Section 103 -
Designates the Deputy Director of National Drug Control Policy as the Acting Director in the absence of the Director. Expands the duties of the Director of the Office to include:
(1) coordination of private sector research and development of medications to treat addiction;
(2) involvement of state and local officials in the formulation and implementation of the National Drug Control Strategy;
(3) monitoring of the allocation of resources among federal law enforcement agencies in response to significant local and regional drug trafficking and production threats; and
(4) reporting annually to Congress on coordination of the Office with state and local governments in the formulation and implementation of the Strategy.
Establishes the position of U.S. Interdiction Coordinator for the coordination of drug interdiction operations among National Drug Control Program agencies.
Section 104 -
Requires annual reports (by July 1) to the Director and Congress from: (1) the Secretaries of Agriculture and the Interior on illegal drug cultivation and manufacturing; and (2) the Secretaries of Homeland Security and Defense on drug seizures and air and maritime patrols.
Section 105 -
Revises National Drug Control Program budgetary procedures to: (1) require budget requests to include all funding requests for any drug control activity, including any drug law enforcement activities; (2) prohibit the Director from certifying a budget request which does not meet certain basic standards for drug control programs; and (3) require fund control notices to be transmitted to specified congressional committees.
Requires the Director to report to the President by August 1 of each year on an assessment of major drug transit and illicit drug producing countries.
Title II - The National Drug Control Strategy
Section 201 -
Revises requirements for the development, submission, implementation, and assessment of the National Drug Control Strategy. Requires the President to submit the Strategy to Congress not later than February 1 of each year.
Requires the Strategy to include:
(1) assessments of current illicit drug use, availability of illicit drugs, and reductions in drug use and availability;
(2) a determination of the status of drug treatment in the United States;
(3) a review of the research agenda of the Counterdrug Technology Assessment Center; and
(4) a summary of efforts made to coordinate with the private sector to conduct research and development of medications to treat addiction.
Requires the Director to consult with the heads of the National Drug Control Program agencies, Congress, state and local officials, private citizens and entities, and representatives of foreign governments in developing and implementing the Strategy.
Section 202 -
Requires the Director to submit to Congress by February 1 of each year a description of a national drug control performance measurement system as part of the Strategy.
Section 203 -
Requires the Director to report to Congress on or before February 1 of each year on the national drug control media campaign. Requires the Government Accountability Office to conduct yearly audits of the Office of National Drug Control Policy and certain programs within such Office.
Title III - High Intensity Drug Trafficking Areas
Section 301 -
Revises the High Intensity Drug Trafficking Areas (HIDTA) Program to:
(1) identify specific purposes of such Program relating to inter-governmental cooperation and intelligence sharing;
(2) allow coalitions of law enforcement agencies to petition for the designation of a high intensity drug trafficking area;
(3) require the appointment of an Executive Board to manage such an area;
(4) limit the use of HIDTA Program funding for the establishment of drug prevention programs; and
(5) authorize the Director to use HIDTA Program funds to assist law enforcement agencies in terrorism prevention activities, to respond to emerging drug trafficking threats in such areas, and to combat methamphetamine trafficking in such areas.
Requires the Director to report to Congress on assessments of : (1) designated high intensity drug trafficking areas; (2) drug enforcement task forces within each such area; and (3) intelligence sharing in such areas.
Authorizes appropriations for FY2007-FY2011.
Section 302 -
Dawson Family Community Protection Act - Requires the Director to allocate at least $7 million for high intensity drug trafficking areas with severe neighborhood safety and illegal drug distribution problems. Specifies the required uses of such funds as: (1) ensuring the safety of communities and preventing intimidation of potential witnesses of illegal drug distribution; and (2) combating illegal drug trafficking.
Section 303 -
Requires the Director to: (1) assess the ability of the HIDTA Program to respond to the movement of drug traffickers into rural, suburban, and smaller urban areas; and (2) conduct a demonstration project to assess the ability of the New York/New Jersey HIDTA Program to respond to the movements of such drug traffickers.
Title IV - Technology
Section 401 -
Replaces the Director of Technology of the Counterdrug Technology Assessment Center with a Chief Scientist. Sets forth the responsibilities of the Chief Scientist, including the coordination and implementation of a counterdrug technology transfer program for transferring technology and associated training directly to state and local law enforcement agencies.
Requires the Director to report to Congress by July 1 of each year on the counterdrug technology transfer program.
Title V - Reauthorization and Improvement of the National Anti-Drug Media Campaign
Section 501 -
National Youth Anti-Drug Media Campaign Reauthorization Act of 2006 - Amends the Drug-Free Media Campaign Act of 1998 to rename the national media campaign as the national youth anti-drug media campaign and to include as purposes of such campaign: (1) increasing awareness of adults of the impact of drug abuse on young people; and (2) encouraging parents to discuss with young people the dangers of illegal drug use.
Section 503 -
Requires the Director, in consultation with the Partnership for a Drug-Free America, to determine the overall purposes and strategy of the campaign.
Delegates to the Partnership for a Drug-Free America responsibility for: (1) developing and recommending strategies to achieve the goals of the campaign; and (2) the creation of advertising to be used in the campaign.
Requires the Director to contract with a media buying contractor to plan and purchase advertising time and space for the campaign.
Section 504 -
Establishes standards, limitations, and matching requirements for the use of federal funds for the campaign
Section 505 -
Authorizes appropriations for FY2006-FY2010.
Title VI - Authorizations and Extension of Termination Date
Section 601 -
Authorizes appropriations for ONDCPRA for FY2006-FY2010 and extends its termination date until September 30, 2010 (previous termination date was September 30, 2003).
Title VII - Anti-Doping Agency
Section 701 -
Designates the U.S. Anti-Doping Agency as the independent anti-doping organization for the amateur athletic competitions recognized by the U.S. Olympic Committee and sets forth its duties. Requires the Agency to: (1) keep correct and complete records of account; and (2) submit an annual report to Congress which includes an audit and description of Agency activities.
Authorizes appropriations for FY2007-FY2011.
Title VIII - Drug-Free Communities
Section 801 -
Amends the Drug-Free Communities Act of 1997 to:
(1) authorize appropriations for FY2008-FY2012;
(2) increase from $100,000 to $125,000 the maximum grant amount allowed under the Act;
(3) prohibit the Director from imposing any new eligibility criteria on new or renewing grant applicants;
(4) authorize the Director to make initial and renewal grants to coalitions dealing with a major local drug crisis; and
(5) require the Director to delegate all authority for grant eligibility determinations, review, selection, management, and appeals to another qualified national drug control agency.
Section 802 -
Requires drug-free communities program grantees to be afforded a fair, timely, and independent appeal before suspension or termination for noncompliance with grant criteria. Requires the Director to report to Congress on the appeals process established by this Act.
Section 806 -
Requires the Director to make a directed grant to Community Anti-Drug Coalitions of America to provide for the continuation of the National Community Antidrug Coalition Institute. Authorizes appropriations for FY2008-FY2012.
Title IX - National Guard Counterdrug Schools
Section 901 -
Authorizes the Chief of the National Guard Bureau to establish and operate five schools to be known as National Guard counterdrug schools to provide training in drug interdiction and counterdrug activities and drug demand reduction activities to:
(1) federal agencies;
(2) state and local law enforcement agencies; and
(3) community-based organizations and other non-governmental private entities engaged in counterdrug activities.
Identifies such schools as:
(1) the National Interagency Civil-Military Institute, San Luis Obispo, California;
(2) the Milti-Jurisdictional Counterdrug Task Force Training, St. Petersburg, Florida;
(3) the Midwest Counterdrug Training Center, Johnston, Iowa;
(4) the Regional Counterdrug Training Academy , Meridian, Mississippi; and
(5) the Northeast Regional Counterdrug Training Center, Fort Indiantown Gap, Pennsylvania.
Directs the Secretary of Defense to report to Congress by February 1 of each year on the activities of the National Guard counterdrug schools during the preceding year.
Authorizes appropriations for FY2006-FY2010.
Title X - National Methamphetamine Information Clearinghouse Act Of 2006
Section 1001 -
National Methamphetamine Information Clearinghouse Act of 2006 - Establishes: (1) the National Methamphetamine Information Clearinghouse under the supervision of the Attorney General; and (2) the National Methamphetamine Advisory Council.
Section 1004 -
Directs the Clearinghouse to: (1) promote information sharing on successful programs relating to methamphetamine production, use, or effects, and grants available for such programs; and (2) include a toll-free number and a website.
Section 1005 -
Authorizes appropriations for FY2006-FY2010.
Title XI - Miscellaneous Provisions
Section 1101 -
Repeals provisions of ONDCPRA relating to: (1) the President's Council on Counter-Narcotics and the Parents Advisory Council on Youth Drug Abuse; and (2) drug interdiction. Repeals provisions of the Assets Forfeiture Amendments Act of 1988 establishing a Special Forfeiture Fund.
Section 1102 -
Amends the Controlled Substances Act to permit non-group medical practitioners to dispense narcotic drugs for drug maintenance and detoxification treatment to more than 30 patients at any one time after giving certain notifications and certifications to the Secretary of Health and Human Services.
Requires the Director to submit to Congress:
(1) a report on intelligence systems and sharing for combating drug trafficking and production;
(2) a comprehensive strategy to address the heroin threat from Columbia and other South American countries;
(3) a study on iatrogenic addiction associated with prescription opioid analgesic drugs;
(4) a strategy to stop Internet advertising to obtain prescription drugs without a lawful prescription; and
(5) a plan to conduct a study on the illegal diversion and inappropriate uses of prescription drugs.
Section 1105 -
Requires the Director to contract with a nonprofit corporation to revise model state drug laws. Authorizes appropriations.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of S. 2560 (109th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus